📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
2
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BAH.
💹 Market Data
Market Cap$9.71B
Shares Outstanding119.75M
Float118.41M
Cash$728.00M
Debt$4.12B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 3.9% shares (2025Q4 vs prior)
634 institutional holders · 133.36M shares
#1
VANGUARD GROUP INC
13.95M shares
#2
BlackRock, Inc.
13.49M shares
#3
T. Rowe Price Investment Management, Inc.
10.72M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest7.99M
Days to Cover6.4
% of Float6.8%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BAH
📊 BAH FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BAH Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.